Humana Aktie
| 235,78USD | -4,07USD | -1,70% |
WKN: 856584 / ISIN: US4448591028
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99,78 |
| The Vanguard Group, Inc. | 9,28 |
| Vanguard Group, Inc. (Subfiler) | 8,76 |
| Wellington Management Co. LLP | 4,45 |
| State Street Corp. | 4,45 |
| Dodge & Cox | 4,10 |
| Wellington Management Co. LLP (Wellington Breakout) | 3,63 |
| T. Rowe Price Associates, Inc. (IM) | 3,24 |
| Capital Research & Management Co. (International Investors) | 3,22 |
| BlackRock Fund Advisors | 3,20 |
| Vanguard Total Stock Market ETF | 3,16 |
| Dodge & Cox Stock Fund | 2,75 |
| Eagle Capital Management LLC | 2,70 |
| Vanguard 500 Index Fund | 2,65 |
| Geode Capital Management LLC | 2,34 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 47 200 | 49 600 | 96 900 | 67 100 | 67 600 |
| Umsatz pro Mitarbeiter in Mio. EUR | 1,38 | 1,56 | 0,86 | 1,38 | 1,57 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 19 888 | 23 641 | 24 893 | 26 183 | 29 986 |
| Summe Anlagevermögen | 9 155 | 11 436 | 19 855 | 17 542 | 16 906 |
| Summe Aktiva | 29 043 | 35 077 | 44 748 | 43 725 | 46 892 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 17 006 | 21 349 | 28 645 | 28 355 | 30 574 |
| Summe Eigenkapital | 12 037 | 13 728 | 16 103 | 15 370 | 16 318 |
| Summe Passiva | 29 043 | 35 077 | 44 748 | 43 725 | 46 892 |
Adresse
| 500 West Main Street, 40202 Louisville | |
| Telefon | +1 (502) 580-1000 |
| Fax | +1 (502) 580-3677 |
| Internet | http://www.humana.com |
Management
|
Amy K. Smith
Vice President-CFO Home Solutions |
|
Bono Raquel Cruz
Independent Director |
|
Brad D. Smith
Independent Director |
|
Carolyn Tandy
Senior VP, Chief Inclusion & Diversity Officer |
|
David T. Feinberg
Independent Director |
|
Douglas A. Edwards
SVP-Enterprise Associate & Business Solutions |
|
Eric Tagliere
Chief Technology Officer |
|
Frank A. D'Amelio
Independent Director |
|
George Renaudin
President-Medicare & Medicaid |
|
Gordon A. Smith
Independent Director |
|
J. Nwando Olayiwola
Chief Health Equity Officer & Senior VP |
|
James Rechtin
President, Chief Executive & Operating Officer |
|
Jennifer Mumby Bazante
Chief Marketing Officer & Senior Vice President |
|
John W. Garratt
Independent Director |
|
John-Paul W. Felter
Chief Accounting Officer, SVP & Controller |
|
Jorge S. Mesquita
Independent Director |
|
Joseph C Ventura
Chief Legal Officer |
|
Joseph M. Ruschell
Secretary & VP-Associate General Counsel |
|
Karen W. Katz
Independent Director |
|
Katherine H. Goodrich
Chief Medical Officer & Senior Vice President |
|
Kurt J. Hilzinger
Chairman |
|
Lisa Stoner
Vice President-Investor Relations |
|
Marcy S. Klevorn
Independent Director |
|
Nancy A. Hanewinckel
Manager-Media Relations |
|
Sam Deshpande
Chief Information Officer |
|
Sanjay K. Shetty
President-CenterWell |
|
Susan M. Diamond
Chief Financial Officer |
|
Timothy S. Huval
Chief Administrative Officer |
|
Vishal Agrawal
Chief Strategy & Corporate Development Officer |
|
Wayne A. I. Frederick
Independent Director |
|
William Kevin Fleming
Chief Corporate Affairs Officer |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
